These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3879938

  • 1. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA, Vanderpool L, Wesselman J.
    J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
    [No Abstract] [Full Text] [Related]

  • 2. Clavulanic acid/antibiotic ratios.
    Rolinson GN.
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract] [Full Text] [Related]

  • 3. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
    Villiger JW.
    N Z Med J; 1986 Nov 26; 99(814):914. PubMed ID: 3492692
    [No Abstract] [Full Text] [Related]

  • 4. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M, Stucki ZN, Torbert DP, Olweny J.
    J Am Osteopath Assoc; 2005 Jan 26; 105(1):25-6. PubMed ID: 15710671
    [No Abstract] [Full Text] [Related]

  • 5. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP.
    Antibiot Khimioter; 1997 Jan 26; 42(12):29-32. PubMed ID: 9480651
    [No Abstract] [Full Text] [Related]

  • 6. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
    Wallace RJ, Nash DR, Johnson WK, Steele LC, Steingrube VA.
    J Infect Dis; 1987 Dec 26; 156(6):959-66. PubMed ID: 3500241
    [Abstract] [Full Text] [Related]

  • 7. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL, Jones RN, Packer RR.
    J Antimicrob Chemother; 1986 Jan 26; 17(1):125-7. PubMed ID: 3005222
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity and disk susceptibility of Timentin: current status.
    Fuchs PC, Barry AL, Jones RN.
    Am J Med; 1985 Nov 29; 79(5B):25-32. PubMed ID: 4073092
    [No Abstract] [Full Text] [Related]

  • 9. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH, Spohr M.
    Chemotherapy; 1987 Nov 29; 33(5):340-6. PubMed ID: 3117502
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of timentin.
    Thomas MG, Lang SD.
    N Z Med J; 1985 May 22; 98(779):403-4. PubMed ID: 3857527
    [No Abstract] [Full Text] [Related]

  • 11. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J, Hupková M, Krcméry V.
    Cas Lek Cesk; 1995 Sep 06; 134(17):558-61. PubMed ID: 7553760
    [Abstract] [Full Text] [Related]

  • 12. Timentin resistance.
    Masterton RG, Garner PJ, Harrison NA, Rainford DJ.
    Lancet; 1987 Oct 24; 2(8565):975-6. PubMed ID: 2889900
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
    Pierard D, De Meyer A, Rosseel P, Van Cauwenbergh M, Struelens MJ, Delmee M, Goossens H, Claeys G, Glupczynski Y, Verbist L, Melin P, Lauwers S.
    Acta Clin Belg; 1996 Oct 24; 51(2):70-9. PubMed ID: 8693871
    [Abstract] [Full Text] [Related]

  • 14. In vitro efficacy of augmentin in beta-lactamase producing bacteria.
    Agrawal SK, Goel MM, Misra AB.
    Indian J Med Res; 1987 Sep 24; 86():298-300. PubMed ID: 3501408
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B, Chanal M, Sirot D, Cluzel M, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1986 May 24; 17 Suppl C():27-33. PubMed ID: 3522530
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R, Beale AS, Boon RJ, Griffin KE, Slocombe B, Stokes DH, White AR.
    Am J Med; 1985 Nov 29; 79(5B):13-24. PubMed ID: 3878080
    [Abstract] [Full Text] [Related]

  • 17. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
    Traub WH.
    Chemotherapy; 1985 Nov 29; 31(2):119-23. PubMed ID: 3872778
    [Abstract] [Full Text] [Related]

  • 18. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH, Eggleston M.
    Infect Control; 1987 Jan 29; 8(1):36-40. PubMed ID: 3028975
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of piperacillin v timentin and ticarcillin.
    Bremner DA.
    N Z Med J; 1987 May 13; 100(823):299-300. PubMed ID: 3138579
    [No Abstract] [Full Text] [Related]

  • 20. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE, Slocombe B.
    J Chemother; 1989 Jul 13; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.